Reducing Stroke Risk in African-American Men
TEAM2
1 other identifier
interventional
160
1 country
1
Brief Summary
The project is a 6-month prospective Randomized Controlled Trial evaluating the effects of TargEted MAnageMent Intervention (TEAM, N=80) vs. wait-list (WL, N=80) control in African American men who have experienced a stroke or TIA within the past 5 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable stroke
Started May 2020
Longer than P75 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 5, 2020
CompletedFirst Submitted
Initial submission to the registry
May 15, 2020
CompletedFirst Posted
Study publicly available on registry
May 26, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 8, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 8, 2025
CompletedMay 4, 2026
April 1, 2026
5.3 years
May 15, 2020
April 28, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
TEAM vs WL change in systolic BP
TEAM vs WL change in systolic BP
Baseline to 6-month follow up
Secondary Outcomes (7)
TEAM vs WL change in diastolic BP
Baseline to 6-month follow up
TEAM vs WL change in cholesterol
Baseline to 6-month follow up
TEAM vs WL change in HDL
Baseline to 6-month follow up
TEAM vs WL change in LDL
Baseline to 6-month follow up
TEAM vs WL change in triglycerides
Baseline to 6-month follow up
- +2 more secondary outcomes
Study Arms (2)
Intervention
EXPERIMENTALParticipants randomized to TEAM intervention for 6 months, then observed for 6 month follow up
Waitlist
OTHERParticipants randomized to waitlist for 6 months, then offered the intervention for 6 months
Interventions
TEAM targets acquisition of self-management expertise and use of healthy behaviors that are intended to reduce stroke risk and burden. TEAM participants will continue in their regular medical care, supplemented by the TEAM intervention. Components are as follows: 1. A 60 minute initial session in which the nurse and the PED meet with the patient who has experienced stroke or TIA. The initial session will cover introductions, orientation, and logistic planning. 2. Five 60-minute group sessions with 6-10 stroke survivors (and their care partners as applicable) held approximately 4 weeks, 6 weeks, 8 weeks, 10 weeks, and 12 week after enrollment. Sessions are co-lead by a nurse and a PED. 3. Six brief telephone sessions implemented after the conclusion of the 5 TEAM group sessions. Calls will be conducted every 2 weeks for 12 weeks. Calls will reinforce group session content, provide social support and facilitate linkage with other care providers.
Eligibility Criteria
You may qualify if:
- Age range 18 to 90
- Self-identified African American male
- Have had a stroke or TIA in the past 10 years based on date of hospital discharge from an acute stroke program or Emergency Room/physician visit for TIA
- Barthel Index (BI) score of \>= 40
- Able to participate in group sessions
- Age range from 18 to 90
- Able to participate in group sessions
- Age range: from 18 to 90
- Self-identified African American male
- Have had a stroke or TIA
- Able to participate in group sessions
- Age range: from 18 to 90
- Able to participate in group sessions
- Is either a family member, friend or other individual who is important in an enrolled peer educator's stroke recovery OR the family member, friend or other individual of someone who has had a stroke or TIA and is/was important in their stroke recovery
You may not qualify if:
- Individuals who are unable or unwilling to provide written informed consent
- Individuals who have had stroke due to sickle-cell disease
- Individuals who are unable or unwilling to provide written informed consent
- Individuals who have had stroke due to sickle-cell disease
- \. Individuals who are unable or unwilling to provide written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Case Western Reserve University
Cleveland, Ohio, 44106, United States
Related Publications (1)
Still CH, Burant C, Moore S, Einstadter D, Killion C, Modlin C, Sundararajan S, Thornton JD, Wright JT Jr, Sajatovic M. The Targeted Management (TEAM) Intervention for Reducing Stroke Risk in African American Men: Rationale and Study Design of a Prospective Randomized Controlled Trial. J Multidiscip Healthc. 2021 Feb 23;14:513-522. doi: 10.2147/JMDH.S288753. eCollection 2021.
PMID: 33654407DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martha Sajatovic, MD
Case Western Reserve University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 15, 2020
First Posted
May 26, 2020
Study Start
May 5, 2020
Primary Completion
September 8, 2025
Study Completion
September 8, 2025
Last Updated
May 4, 2026
Record last verified: 2026-04